Merck's new injectable cancer drug, Keytruda Qlex, promises to transform patient treatment with a quick administration time and flexible dosing, all while maintaining effectiveness. Available in late September, this shift is critical as the market braces for biosimilar competition.
A groundbreaking study reveals that just one 45-minute workout can boost cancer-fighting proteins in breast cancer survivors, leading to a significant reduction in tumor growth. Learn how exercise could become a vital part of cancer treatment.
